Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

May 07, 2020

Axonics® Announces Proposed Public Offering of Common Stock

May 05, 2020

Axonics® Reports First Quarter 2020 Results

May 04, 2020

Axonics® to Present at Upcoming Investor Conferences

Apr 29, 2020

Axonics® Names Michael H. Carrel as Chairman of its Board of Directors

Apr 14, 2020

Axonics® Announces U.S. Food & Drug Administration Approval of Next Generation Implantable Neurostimulator

Apr 08, 2020

Axonics® to Present at the Needham Healthcare Conference

Apr 07, 2020

Axonics® to Report First Quarter 2020 Financial Results on May 5

Apr 06, 2020

Axonics® Submits PMA Supplement to U.S. Food & Drug Administration to Expand Full-Body MRI Labeling for 3T Scans

Mar 16, 2020

Axonics® Announces Filing of Petitions Before the United States Patent and Trademark Office Contesting the Validity of Medtronic Patents

Mar 04, 2020

Axonics® Announces Fourth Quarter and Fiscal 2019 Financial Results

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

©2020 Axonics Modulation Technologies, Inc. Axonics^® and Axonics Modulation Technologies^® are trademarks of Axonics Modulation Technologies, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap